ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · IEX Real-Time Price · USD
16.90
-0.29 (-1.69%)
Feb 26, 2024, 4:00 PM EST - Market closed
-1.69%
Assets $3.67M
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 246,100
Dividend (ttm) $0.32
Dividend Yield 1.87%
Ex-Dividend Date Dec 20, 2023
Payout Ratio n/a
1-Year Return -19.33%
Volume 6,811
Open 17.14
Previous Close 17.19
Day's Range 16.88 - 17.14
52-Week Low 16.80
52-Week High 26.51
Beta -1.55
Holdings 7
Inception Date Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity
Category Trading--Inverse Equity
Stock Exchange NASDAQ
Ticker Symbol BIS
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology

Dividends

Ex-Dividend Amount Pay Date
Dec 20, 2023 $0.17591 Dec 28, 2023
Sep 20, 2023 $0.11866 Sep 27, 2023
Jun 21, 2023 $0.02137 Jun 28, 2023
Mar 25, 2020 $0.1033 Apr 1, 2020
Dec 24, 2019 $0.1653 Jan 2, 2020
Sep 25, 2019 $0.3247 Oct 2, 2019
Full Dividend History

News

3 ETFs in “Oversold” Territory to Start the Week

Technical analysis can tell investors a lot about both stocks and ETFs, including when some might have been overbought, or even oversold.

Other symbols: DBMFKMLM
1 year ago - ETF Trends

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in develo...

Other symbols: BIBIBBQ
2 years ago - ETF Trends